Management of common bacterial infections of the skin.
Identifieur interne : 000422 ( France/Analysis ); précédent : 000421; suivant : 000423Management of common bacterial infections of the skin.
Auteurs : Philippe Bernard [France]Source :
- Current opinion in infectious diseases [ 0951-7375 ] ; 2008.
Descripteurs français
- KwdFr :
- Antibactériens (usage thérapeutique), Cellulite sous-cutanée (microbiologie), Cellulite sous-cutanée (traitement médicamenteux), Cellulite sous-cutanée (épidémiologie), Dermatoses bactériennes (microbiologie), Dermatoses bactériennes (traitement médicamenteux), Dermatoses bactériennes (épidémiologie), Facteurs de risque, Furonculose (microbiologie), Furonculose (traitement médicamenteux), Furonculose (épidémiologie), Humains, Impétigo (microbiologie), Impétigo (traitement médicamenteux), Impétigo (épidémiologie), Infections communautaires (microbiologie), Résistance à la méticilline, Staphylococcus aureus (pathogénicité), Streptococcus (pathogénicité), Érysipèle (microbiologie), Érysipèle (traitement médicamenteux), Érysipèle (épidémiologie).
- MESH :
- microbiologie : Cellulite sous-cutanée, Dermatoses bactériennes, Furonculose, Impétigo, Infections communautaires, Érysipèle.
- pathogénicité : Staphylococcus aureus, Streptococcus.
- traitement médicamenteux : Cellulite sous-cutanée, Dermatoses bactériennes, Furonculose, Impétigo, Érysipèle.
- usage thérapeutique : Antibactériens.
- épidémiologie : Cellulite sous-cutanée, Dermatoses bactériennes, Furonculose, Impétigo, Érysipèle.
- Facteurs de risque, Humains, Résistance à la méticilline.
English descriptors
- KwdEn :
- Anti-Bacterial Agents (therapeutic use), Cellulitis (drug therapy), Cellulitis (epidemiology), Cellulitis (microbiology), Community-Acquired Infections (microbiology), Erysipelas (drug therapy), Erysipelas (epidemiology), Erysipelas (microbiology), Furunculosis (drug therapy), Furunculosis (epidemiology), Furunculosis (microbiology), Humans, Impetigo (drug therapy), Impetigo (epidemiology), Impetigo (microbiology), Methicillin Resistance, Risk Factors, Skin Diseases, Bacterial (drug therapy), Skin Diseases, Bacterial (epidemiology), Skin Diseases, Bacterial (microbiology), Staphylococcus aureus (pathogenicity), Streptococcus (pathogenicity).
- MESH :
- chemical , therapeutic use : Anti-Bacterial Agents.
- drug therapy : Cellulitis, Erysipelas, Furunculosis, Impetigo, Skin Diseases, Bacterial.
- epidemiology : Cellulitis, Erysipelas, Furunculosis, Impetigo, Skin Diseases, Bacterial.
- microbiology : Cellulitis, Community-Acquired Infections, Erysipelas, Furunculosis, Impetigo, Skin Diseases, Bacterial.
- pathogenicity : Staphylococcus aureus, Streptococcus.
- Humans, Methicillin Resistance, Risk Factors.
Abstract
Bacterial skin infections commonly encountered in the community include impetigo, folliculitis/furunculosis, simple abscesses, erysipelas and other nonnecrotizing cellulitis. The review focuses on recent epidemiological, bacteriological and therapeutic advances.
DOI: 10.1097/QCO.0b013e3282f44c63
PubMed: 18317033
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 003360
- to stream PubMed, to step Curation: 003360
- to stream PubMed, to step Checkpoint: 003360
- to stream Ncbi, to step Merge: 002B97
- to stream Ncbi, to step Curation: 002B97
- to stream Ncbi, to step Checkpoint: 002B97
- to stream Main, to step Merge: 006B33
- to stream Main, to step Curation: 006A32
- to stream Main, to step Exploration: 006A32
- to stream France, to step Extraction: 000422
Links to Exploration step
pubmed:18317033Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Management of common bacterial infections of the skin.</title><author><name sortKey="Bernard, Philippe" sort="Bernard, Philippe" uniqKey="Bernard P" first="Philippe" last="Bernard">Philippe Bernard</name><affiliation wicri:level="3"><nlm:affiliation>Department of Dermatology, Robert Debré Hospital, Reims, France. pbernard@chu-reims.fr</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Dermatology, Robert Debré Hospital, Reims</wicri:regionArea><placeName><region type="region">Grand Est</region><region type="old region">Champagne-Ardenne</region><settlement type="city">Reims</settlement></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2008">2008</date><idno type="RBID">pubmed:18317033</idno><idno type="pmid">18317033</idno><idno type="doi">10.1097/QCO.0b013e3282f44c63</idno><idno type="wicri:Area/PubMed/Corpus">003360</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003360</idno><idno type="wicri:Area/PubMed/Curation">003360</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003360</idno><idno type="wicri:Area/PubMed/Checkpoint">003360</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">003360</idno><idno type="wicri:Area/Ncbi/Merge">002B97</idno><idno type="wicri:Area/Ncbi/Curation">002B97</idno><idno type="wicri:Area/Ncbi/Checkpoint">002B97</idno><idno type="wicri:doubleKey">0951-7375:2008:Bernard P:management:of:common</idno><idno type="wicri:Area/Main/Merge">006B33</idno><idno type="wicri:Area/Main/Curation">006A32</idno><idno type="wicri:Area/Main/Exploration">006A32</idno><idno type="wicri:Area/France/Extraction">000422</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Management of common bacterial infections of the skin.</title><author><name sortKey="Bernard, Philippe" sort="Bernard, Philippe" uniqKey="Bernard P" first="Philippe" last="Bernard">Philippe Bernard</name><affiliation wicri:level="3"><nlm:affiliation>Department of Dermatology, Robert Debré Hospital, Reims, France. pbernard@chu-reims.fr</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Dermatology, Robert Debré Hospital, Reims</wicri:regionArea><placeName><region type="region">Grand Est</region><region type="old region">Champagne-Ardenne</region><settlement type="city">Reims</settlement></placeName></affiliation></author></analytic><series><title level="j">Current opinion in infectious diseases</title><idno type="ISSN">0951-7375</idno><imprint><date when="2008" type="published">2008</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Anti-Bacterial Agents (therapeutic use)</term><term>Cellulitis (drug therapy)</term><term>Cellulitis (epidemiology)</term><term>Cellulitis (microbiology)</term><term>Community-Acquired Infections (microbiology)</term><term>Erysipelas (drug therapy)</term><term>Erysipelas (epidemiology)</term><term>Erysipelas (microbiology)</term><term>Furunculosis (drug therapy)</term><term>Furunculosis (epidemiology)</term><term>Furunculosis (microbiology)</term><term>Humans</term><term>Impetigo (drug therapy)</term><term>Impetigo (epidemiology)</term><term>Impetigo (microbiology)</term><term>Methicillin Resistance</term><term>Risk Factors</term><term>Skin Diseases, Bacterial (drug therapy)</term><term>Skin Diseases, Bacterial (epidemiology)</term><term>Skin Diseases, Bacterial (microbiology)</term><term>Staphylococcus aureus (pathogenicity)</term><term>Streptococcus (pathogenicity)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Antibactériens (usage thérapeutique)</term><term>Cellulite sous-cutanée (microbiologie)</term><term>Cellulite sous-cutanée (traitement médicamenteux)</term><term>Cellulite sous-cutanée (épidémiologie)</term><term>Dermatoses bactériennes (microbiologie)</term><term>Dermatoses bactériennes (traitement médicamenteux)</term><term>Dermatoses bactériennes (épidémiologie)</term><term>Facteurs de risque</term><term>Furonculose (microbiologie)</term><term>Furonculose (traitement médicamenteux)</term><term>Furonculose (épidémiologie)</term><term>Humains</term><term>Impétigo (microbiologie)</term><term>Impétigo (traitement médicamenteux)</term><term>Impétigo (épidémiologie)</term><term>Infections communautaires (microbiologie)</term><term>Résistance à la méticilline</term><term>Staphylococcus aureus (pathogénicité)</term><term>Streptococcus (pathogénicité)</term><term>Érysipèle (microbiologie)</term><term>Érysipèle (traitement médicamenteux)</term><term>Érysipèle (épidémiologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-Bacterial Agents</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Cellulitis</term><term>Erysipelas</term><term>Furunculosis</term><term>Impetigo</term><term>Skin Diseases, Bacterial</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Cellulitis</term><term>Erysipelas</term><term>Furunculosis</term><term>Impetigo</term><term>Skin Diseases, Bacterial</term></keywords><keywords scheme="MESH" qualifier="microbiologie" xml:lang="fr"><term>Cellulite sous-cutanée</term><term>Dermatoses bactériennes</term><term>Furonculose</term><term>Impétigo</term><term>Infections communautaires</term><term>Érysipèle</term></keywords><keywords scheme="MESH" qualifier="microbiology" xml:lang="en"><term>Cellulitis</term><term>Community-Acquired Infections</term><term>Erysipelas</term><term>Furunculosis</term><term>Impetigo</term><term>Skin Diseases, Bacterial</term></keywords><keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en"><term>Staphylococcus aureus</term><term>Streptococcus</term></keywords><keywords scheme="MESH" qualifier="pathogénicité" xml:lang="fr"><term>Staphylococcus aureus</term><term>Streptococcus</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Cellulite sous-cutanée</term><term>Dermatoses bactériennes</term><term>Furonculose</term><term>Impétigo</term><term>Érysipèle</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antibactériens</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Cellulite sous-cutanée</term><term>Dermatoses bactériennes</term><term>Furonculose</term><term>Impétigo</term><term>Érysipèle</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Humans</term><term>Methicillin Resistance</term><term>Risk Factors</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Facteurs de risque</term><term>Humains</term><term>Résistance à la méticilline</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Bacterial skin infections commonly encountered in the community include impetigo, folliculitis/furunculosis, simple abscesses, erysipelas and other nonnecrotizing cellulitis. The review focuses on recent epidemiological, bacteriological and therapeutic advances.</div></front></TEI><affiliations><list><country><li>France</li></country><region><li>Champagne-Ardenne</li><li>Grand Est</li></region><settlement><li>Reims</li></settlement></list><tree><country name="France"><region name="Grand Est"><name sortKey="Bernard, Philippe" sort="Bernard, Philippe" uniqKey="Bernard P" first="Philippe" last="Bernard">Philippe Bernard</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/France/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000422 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/France/Analysis/biblio.hfd -nk 000422 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= France
|étape= Analysis
|type= RBID
|clé= pubmed:18317033
|texte= Management of common bacterial infections of the skin.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/RBID.i -Sk "pubmed:18317033" \
| HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |